Holen Sie sich die Stockscreener-App
7.73
4.57%
-0.37
Handel nachbörslich:
7.65
-0.08
-1.03%
Schlusskurs vom Vortag:
$8.10
Offen:
$7.87
24-Stunden-Volumen:
2.88M
Relative Volume:
2.22
Marktkapitalisierung:
$1.05B
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-6.964
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+13.18%
1M Leistung:
+28.19%
6M Leistung:
-44.15%
1J Leistung:
+25.90%
1-Tages-Spanne:
$7.69
$8.23
1-Wochen-Bereich:
$6.61
$8.39
52-Wochen-Spanne:
$4.25
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
7.73 | 1.05B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Renaissance Technologies LLC Lowers Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Invesco Ltd. Increases Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wells Fargo & Company MN Purchases 22,873 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
WVE Shares Experience Surge in Value - knoxdaily.com
Cantor Fitzgerald Predicts WVE FY2025 Earnings - Defense World
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Wave Life Sciences to Host Webcast for First Quarter 2025 Financial Results and Business Updates - Nasdaq
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 - GlobeNewswire
RNA Medicine Pioneer Wave Life Sciences Sets Q1 2025 Earnings Call for May 8 - Stock Titan
Cantor Fitzgerald Initiates Coverage on Wave Life Sciences (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) Stock: From Low to High in 52 Weeks - investchronicle.com
Wave Life Sciences Ltd (NASDAQ: WVE): Why Investors Shouldn’t Ditch WVE Stock In 2025 - Marketing Sentinel
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts - Benzinga
Wave Life Sciences Ltd (WVE) looking to reclaim success with recent performance - Sete News
Cantor Fitzgerald sets WAVE Life Sciences stock at Overweight By Investing.com - Investing.com India
Cantor Fitzgerald Initiates Wave Life Sciences at Overweight With $10 Price Target - marketscreener.com
Wave Life Sciences (WVE) Receives Overweight Rating and $10 Pric - GuruFocus
Wedbush analysts initates an Outperform rating for Wave Life Sciences Ltd (WVE) - knoxdaily.com
Can you now get a good deal on Wave Life Sciences Ltd’s shares? - uspostnews.com
Duchenne Muscular Dystrophy Treatment Market Growth, Trends & - openPR.com
Check Out Wave Life Sciences Ltd (WVE)’s Trade Data Rather Than the Analysts’ Views - Sete News
Analysts Say Wave Life Sciences Ltd (NASDAQ:WVE) Can Really Get To 36 In 12 Months - Marketing Sentinel
A stock that deserves closer examination: Wave Life Sciences Ltd (WVE) - uspostnews.com
Daily Market Movement: Wave Life Sciences Ltd (WVE) Sees a 3.51 Increase, Closing at 6.79 - DWinneX
Russell Investments Group Ltd. Purchases 43,398 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) rating initates by Wedbush - knoxdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of “Buy” by Brokerages - Defense World
(WVE) Investment Report - news.stocktradersdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - Defense World
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Franklin Resources Inc. Trims Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Raised by Geode Capital Management LLC - Defense World
Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely? - Yahoo
Vanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid FDA Timeline Concerns | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid F - GuruFocus
B. Riley Adjusts Wave Life Sciences' Price Target to $19 From $22, Keeps Buy Rating - MarketScreener
Wave Life Sciences (NASDAQ:WVE) Coverage Initiated by Analysts at Wedbush - Defense World
Wedbush sets $18 target for WAVE Life Sciences stock By Investing.com - Investing.com India
Wedbush sets $18 target for WAVE Life Sciences stock - Investing.com Australia
Wedbush Initiates Wave Life Sciences at Outperform With $18 Price Target - marketscreener.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Sei Investments Co. - Defense World
KLP Kapitalforvaltning AS Acquires New Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
(WVE) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 41% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $10 From $14, Keeps Sector Perform, Speculative Risk - MarketScreener
Wave Life Sciences’ SWOT analysis: RNA editing pioneer faces challenges in genetic medicine stock - Investing.com India
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance
What is Leerink Partnrs’ Estimate for WVE Q1 Earnings? - Defense World
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance
HC Wainwright Reaffirms “Buy” Rating for Wave Life Sciences (NASDAQ:WVE) - Defense World
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):